Page last updated: 2024-11-07

4-hydroxy-25-desoxyneorollinicin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-hydroxy-25-desoxyneorollinicin: isol from Rollina papilionella; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID130056
CHEMBL ID503360
SCHEMBL ID217006
MeSH IDM0170858

Synonyms (15)

Synonym
102989-24-2
asimicin
bullatacin
rolliniastatin
CHEMBL503360
4-[2,13-dihydroxy-13-[5-[5-(1-hydroxyundecyl)oxolan-2-yl]oxolan-2-yl]tridecyl]-2-methyl-2h-furan-5-one
annonin vi
3-(2,13-dihydroxy-13-(octahydro-5'-(1-hydroxyundecyl)(2,2'-bifuran)-5-yl)tridecyl)-5-methyl-2(5h)-furanone
4-hydroxy-25-desoxyneorollinicin
oh-donr
129212-94-8
123805-39-0
2(5h)-furanone, 3-(2,13-dihydroxy-13-(octahydro-5'-(1-hydroxyundecyl)(2,2'-bifuran)-5-yl)tridecyl)-5-methyl-
SCHEMBL217006
AKOS024278523

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" An assessment of the potential human health risk of overconsumption of fruit and acetogenin bioavailability and degradation studies should be pursued."( Identification of annonaceous acetogenins in the ripe fruit of the North American pawpaw ( Asimina triloba ).
Crabtree, SB; Keller, W; Lowe, JD; Pomper, KW, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID340565Antitumor activity against mouse P388 cells at 250 ug/kg by in vivo 3PS assay2008Journal of natural products, Jul, Volume: 71, Issue:7
Paw paw and cancer: annonaceous acetogenins from discovery to commercial products.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (58)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's24 (41.38)18.2507
2000's23 (39.66)29.6817
2010's11 (18.97)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.15 (24.57)
Research Supply Index4.14 (2.92)
Research Growth Index4.30 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.23%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other60 (96.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]